IMMEDIATE TRIAL INFORMATION
Home
Study Overview
Study/History Timeline
What is IMMEDIATE GIK?
Patient Enrollment
Participating Sites
Research Team
News and Events
Glossary of Terms
Articles and Resources
WELCOME TO THE IMMEDIATE TRIAL!
The IMMEDIATE (Immediate Metabolic Myocardial Enhancement During Initial Assessment and Treatment in Emergency Care) Trial is a NIH National Heart, Lung, Blood Institute sponsored study that is testing whether giving an Intravenous (IV) solution of readily available medications (Glucose, Insulin and potassium), referred to as “GIK” is helpful to patients at the first signs of a heart attack.
The IMMEDIATE Trial is currently enrolling in the following cities:
Albuquerque
Anchorage
Concord
Macon
New Haven
Sioux Falls
Visit Participating Sites for details.
IMMEDIATE Trial Coordinating Center 
Tufts Medical Center
800 Washington Street, Boston, MA 02111
Toll Free: (877) 636-8756
Phone: (617) 636-8787 - Fax: (617) 636-0022
Email: IMMEDIATE-Trial@tuftsmedicalcenter.org
Copyright 2006, Tufts-NEMC - Last Updated: 10/17/08
  Massachusetts
  Texas
  Wisconsin
  Inclusion/Exclusion Criteria
  Enrollment Process
  Community Consultation & Public Notification  
  What is a Clinical Trial?
  Heart Attack Facts
  Frequently Asked Questions
  Biological Mechanism Cohort
  Abstract
  Background
  Study Design and Procedures
  ECG Predictive Instruments
  Paramedic Training